Osteopetrotic (op/op) mice are characterized by an autosomal recessive inactivating mutation resulting in the absence of biologically active colony-stimulating factor-l (CSF-1). Consequently, young op/op mice have a severe deficiency of macrophages and osteoclasts resulting in excessive bone formation, occlusion of the marrow cavity, and reduced marrow hematopoietic activity. Recently, we showed that the osteopetrosis and hematopoietic deficiencies evident in young op/op mice are not permanent but are progressively corrected with age. There are increases in osteoclast activity; bone resorption; femoral marrow space; and marrow hematopoietic activity, cellularity, and macrophage content. In the present study we show that CSF-1"-granulocyte-macrophage colony-stimulating factor (GM-CSF)"--deficient mice also undergo the same pattern of hematopoietic correction STEOPETROTIC (op/op) mice are characterized by an autosomal recessive inactivating mutation in the colony-stimulating factor-1 (CSF-1) gene, resulting in the absence of biologically active CSF-1 which has a lineagespecific role in augmenting macrophage production and function in As a consequence, young op/op mice have impaired mononuclear phagocyte development and a deficiency of both macrophages and osteoclasts, resulting in an increase in bone density and occlusion of marrow cavities.'-"
Previous studies have indicated that the daily administration of CSF-1 to newborn op/op mice can prevent osteopetrosis and the accompanying hematopoietic defects."." Our previous studie~'~"' have shown a naturally occurring, progressive, age-related systemic correction in hematopoietic parameters in op/op mice. This finding suggests that the hematopoietic system has the capacity to use alternative mechanisms to compensate for the absence of CSF-I l 4 and raises the possibility of plasticity amongst previously regarded key growth factors." It is interesting that exogenous administration of the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) to as the op/op mouse. Also, like the op/op mouse, the peritoneal cellularity and macrophage content of CSF-l/GM-CSFdeficient mice remains severely reduced. Our data show that the "knockout" of GM-CSF does not change the op/op phenotype, and that GM-CSF is not essential for the correction of the hematopoietic deficiencies in the op/op mouse. Importantly, the data also show that neither GM-CSF nor CSF-I is an absolute requirement for the commitment of primitive hematopoietic stem cells to the macrophage lineage or for the differentiation of at least some classes of macrophages. This finding suggests that an alternate regulatory factor can be involved in macrophage and osteoclast commitment, differentiation, and function in vivo. 0 7995 b y The American Society of Hematology.
young op/op mice corrects the macrophage deficiencies but fails to resolve osteopetrosis.'"2o GM-CSF stimulates the survival, proliferation, differentiation, and function of myeloid cells and their precursors, particularly monocytes and macrophages, as well as granulocytes." However, analysis of op/op mice indicates that, whereas inducible levels of endogenous GM-CSF are elevated in some animals, this is not always the case. 3 The most definitive means of assessing the role of hematopoietic regulators in vivo is to study mice that are deficient in one or more hematopoietic growth factors. Recently, GM-CSF-deficient mice were produced by gene targeting in embryonal stem cells."
GM-CSF-deficient mice were shown to be relatively unperturbed in terms of circulating hematopoietic cells and progenitor cell levels in hematopoietic organs.
In the present study, we have analyzed mice deficient in both CSF-1 and GM-CSF (CSF-I"-GM-CSF" ) that were produced by interbreeding op/op mice with GM-CSF-deficient mice." A thorough comparison of the hematopoietic system of young (5 weeks of age) and mature (40 weeks of age) CSF-1 -'-GM-CSF"-mice and their wild-type littermates was undertaken. The data showed that, for all the hematopoietic parameters measured, mice deficient in both CSF-1 and GM-CSF have the phenotype of the op/op mouse.
This finding extends to both the deficiencies evident in young mice, as well as to the progressive, age-related corrections evident in maturing op/op mice. The data show that GM-CSF is not essential for the correction of the hematopoietic deficiencies in op/op mice and suggest that an alternate regulatory factor can be involved in macrophage and osteoclast commitment, differentiation, and function in vivo. This may be an as yet unidentified factor or may be a manifestation of plasticity amongst the known hematopoietic growth factors.
MATERIALS AND METHODS

Mice. Mice deficient in
CSF-1 (op/op) and/or GM-CSF, as well as wild-type genotypes, were generated and raised as previously described. ' Cell suspensions. Marrow cells from both CSF-l+'+GM-CSF-'-and CSF-l+%M-CSF+" mice were collected by flushing femoral shafts with cold HEPES-buffered balanced salt solution (BSS) supplemented with 2% bovine calf serum iron-supplemented (BCS). Femurs from osteopetrotic CSF-l-/-GM-CSF+/+ and CSFl-/-GM-CSF-/-mice were routinely ground using a mortar and pestle, because less than 20% of marrow cells from osteopetrotic mice could be recovered by flushing a l~n e . '~. '~T h e suspensions were gently vortexed to free any cells adhered to bone fragments, and the cell suspension was decanted and pooled, together with three washings of the bone fragments.
Spleen cell suspensions were prepared by mincing the tissue in BSS supplemented with 2% BCS and by dispersion through a mesh sieve.
Peripheral blood was collected from a throat bleed into an EDTAcoated tube and mixed well. Excessive red blood cells contaminating the samples were lysed with 0.83% ammonium chloride (10 mL per 1 mL of red blood cell pellet) at 37°C for 5 minutes, and cells were then washed twice with BSS-2% BCS.
Peritoneal cells were collected by injecting 10 mL of BSS-2% BCS into the peritoneal cavity using a 23-gauge needle. The peritoneum was gently massaged, without removing the needle tip, to free loosely adherent cells before aspirating the solution. The cells were centrifuged at 1,000 rpm at 4°C for 5 minutes and resuspended in BSS-2% BCS.
Cell counts were performed using a hemocytometer. Growthfactors. Partially purified pregnant mouse uterus extract was used as a source of CSF-1.24 Recombinant human interleukin-1 (IL-l: 2.5 x lo9 Ulmg protein) was a gift from Hoffman-La Roche Inc (Nutley, NJ). Recombinant murine IL-3 was prepared as conditioned medium from the genetically altered mouse mammary cell line (C127) expressing the mouse cDNA.'~ All factors were used at optimal concentrations.26
Hematopoietic progenitor cell assays. Marrow cell suspensions were assayed for low and high proliferative potential colony-forming cells (LPP-CFC and HPP-CFC), using a double-layer nutrient agar culture system exactly as previously described.26 After 14 days of incubation, HPP-CFC typically generated colonies greater than 0.5 mm in diameter consisting of tightly packed cells. Functionally, these cells are defined as primitive cells by their relative resistance to 5-FU, their synergistic growth factor requirements, and their copurification with long-term reconstituting cells in v~v o . *~~~* LPP-CFC are macrophage lineage-restricted cells responsive to CSF-1 alone and typically generate colonies measuring less than 0.5 mm in diameter.29
Monoclonal antibodies (MoAbs). A panel of rat MoAbs was used to investigate age-related changes in the expression of hematopoietic lineage cell surface antigens in each cell suspension. These antibodies included anti-714 (neutrophils, activated macrophages, and macrophage lineage-restricted progenitor^)^'; antGB220 (B cells)3' ; anti-MAC-I3' and a11ti-F4/80~~ (macrophage subsets); anti-L3T4(CD4) and anti-Lyt-2 (CD8) (T cells)34; and anti-GR-l (neut r o p h i l~) .~~ Antibodies were diluted in phosphate-buffered saline (PBS) (pH 7.4, 290 mOsm) supplemented with 5% BCS (binding buffer) and used at predetermined optimal dilutions.
Flow cytometric analysis. Cells were labeled using equal volumes of primary antibody and binding buffer for 30 minutes on ice and then washed three times and incubated with mouse serumadsorbed fluorescein isothiocyanate (FITC)-conjugated goat antirat IgG (H+L; Kirkegaard and Perry Laboratories, Gaithersburg, MD) for a further 30 minutes on ice. The cells were washed a further three times, resuspended in PBS supplemented with 0.25% BCS, and held at 4°C before flow cytometric analysis.
Labeled cells were analyzed using a FACStarP'"s cell sorter (Becton Dickinson, Mountain View, CA) equipped with a 5-W argon ion laser (Coherent Innova 90, Palo Alto, CA) running at 200 mW of power. Light-scatter signals were collected through a 488-nm band pass filter in the forward light scatter path. Background fluorescence (cell surface binding of FITC-conjugated goat antirat second antibody) was less than 5%.
Preparation of microscopic sections. Tibiae removed from anesthetized (Penthrane; Abbott Laboratories, North Chicago, IL) mice were immersion fixed in 2% formaldehyde and 2% glutaraldehyde for 48 hours, washed in sucrose buffer, and decalcified in 10% EDTA for 2 weeks. Dehydration in graded ethanol was followed by infiltration and embedding in Polaron embedding medium (Biorad, Cambridge, MA). Three-micrometer sections were cut and stained with Giemsa (BDH Chemicals, Kilsyth, Victoria, Australia).
Statistics. Analysis of accumulated data involved testing the difference between paired groups of wild-type mice (CSF-l+/+GM-CSF'") from different experiments using the Wilcoxon matched pairs test. Because no significant difference was detected, accumulated data were pooled and the differences between means of each age-matched genotype were evaluated by one-way analysis of variance (ANOVA). Significance was then tested using the Newmad Keul's range test.
RESULTS
Young (5 weeks old) CSF-l-"GM-CSF-'-mice weighed significantly less than their wild-type littermates, although, like the op/op (CSF-l"-GM-CSF+/+) mouse, by 40 weeks of age, no difference could be detected between the weights of CSF-l-"GM-CSF-" and either op/op mice or wild-type littermates (Table 1) .
Age-related changes in bone marrow cellularity and hematopoiesis. Young CSF-l-/-GM-CSF-/-mice had a severe deficiency in marrow cellularity similar to that observed in aged-matched op/op mice. By 5 weeks of age, the femoral marrow cellularity of wild-type mice had attained adult levels. In contrast, by 5 weeks of age, the femoral marrow cellularity of CSF-l-"GM-CSF-'-mice was only 3.9 X lo6 cells per femur, or 18% of the cellularity of wild-type femurs (Table 1) . However, CSF-l-'-GM-CSF-/-mice subsequently demonstrated an age-related correction in femoral cellularity identical to that observed in the op/op mouse.I4 By 40 weeks of age, the femoral marrow cellularity of CSF-1 -/-GM-CSF-/-mice had become comparable to that of both op/op and wild-type littermate mice (Table 1) .
Flow cytometric analysis of the expression of the cell surface antigen F4/80 also showed a similar age-related correction of the marrow macrophage deficiency observed in young CSF-1 -/-GM-CSF-" mice (Table 1) as that observed in maturing op/op At 5 weeks of age, the proportion of F4/80+ cells was approximately 75% that of wild-type marrow. By 40 weeks of age, the proportion of F4/80+ cells was comparable to that of wild-type. Because the femoral bone marrow cellularity in mature CSF-lPGM-CSF-/-mice and wild-type mice was also comparable, the total numbers of F4/80+ cells per femur were also equivalent.
The presence of equal proportions of macrophages in mature CSF-l-/-GM-CSF-", op/op, and wild-type mice was confirmed by light microscopy (data not shown). These cells were clearly distinguishable from other cell types by the presence of paracrystalline inclusions, which are characteristic of bone marrow macrophages in normal mice older than 60 days.36," At 5 weeks of age, both young CSF-l-/-GM-CSF-/-and op/op mice had a significant increase in the proportion of MAC-1' cells and Gr-l+ cells compared with that of their wild-type littermates (Table 1 ). This increase in the proportion of MAC-l+ cells was most likely caused by the increase in granulocytes, because the MAC-l antigen is expressed by both macrophages and granulocytes. Also, as previously described, there was a lower incidence of F4/80+ macrophages in both young CSF-l-/-GM-CSF-/-and op/op mice compared with wild-type littermates. There was also no evidence of the upregulation of MAC-l antigen expression, reflected by a shift in mean channel fluorescence (data not shown). However, the absolute number of GR-1' cells per femur in both young CSF-l-/-GM-CSF-/-and op/op mice was markedly reduced compared with wild-type control values (1.9 t 0.6,2.9 f 0.4, and 6.9 5 1.3 X lo6, respectively).
At 5 weeks of age, there was also a significant decrease in both the proportion (Table 1 ) and total numbers of B220' lymphocytes in both CSF-l-/-GM-CSF-/-and op/op femurs compared with that of their wild-type littermates (0.5 t 0.2, 1 . l -t 0.2, and 10.0 1.0 X lo6, respectively). Although, by 40 weeks of age, the proportion (Table 1 ) and total number of B220+ cells was comparable in CSF-l-/-GM-CSF-/-, op/ op, and wild-type mice.
The hematopoietic potential of CSF-1 "-GM-CSF-'-femoral bone marrow was evaluated by in vitro clonal assay of committed (LPP-CFC) and primitive (HPP-CFC) progenitors. There were no differences in the incidence of LPP-CFC or HPP-CFC in the marrow of CSF-l-"GM-CSF-/-and wild-type mice at any age examined (data not shown). Therefore, the total femoral content of these progenitors (Table 2) reflected the age-related changes observed in marrow cellularity (Table l) . By 40 weeks of age, the femoral content in CSF-l-/-GM-CSF-", op/op, and wild-type mice was comparable (Table 2) .
Age-related changes in splenic hematopoiesis. Like young op/op m i~e , '~, '~ the diminished space for marrow hematopoiesis and the reduced marrow hematopoietic activity in young CSF-i"-GM-CSF-" mice correlated with an increase in splenic hematopoiesis. Although young CSF-1-/-GM-CSF-I-mice weighed significantly less than their wildtype littermates (Table l) , there was evidence of splenomegaly, with an average spleen cellularity 1.5 times (Table 3 ) and a spleen weight 1.3 times that of their wild-type littermates (data not shown). The primitive and committed progenitor cell incidence and content, as evaluated by the in vitro clonal assay of LPP-CFC and HPP-CFC, were also significantly elevated. Young CSF-1 -/-GM-CSF-/-mice had an average increase in the incidence of LPP-CFC and HPP-CFC 2-and 10-fold that of wild-type littermates, respectively ( Table 4) .
Evidence of extramedullary hematopoiesis in the spleen of young CSF-l-/-GM-CSF-/-mice was confirmed by flow cytometric analysis (Table 3 ). At 5 weeks of age, spleens from CSF-l-/-GM-CSF-/-mice were characterized by an increase in granulocytopoiesis similar to that seen in the op/ op mouse. There was a 39%, 32%, and 76% increase in the proportion of GR-l+, MAC-l+, and F4/80+ cells, and a 75% reduction in the proportion of B220+ cells, respectively ( Table 3 ). This increase in both spleen cellularity and the proportion of GR-l+, MAC-I+, and F4/80+ cells was reflected by a significant increase in the total numbers of these cell types in CSF-1 -/-GM-CSF-/-mice compared with their wild-type controls (4.6 2 0.6,2.0 t 0.4, and 10.2 2 3.0 X IO7, respectively, compared with 2.3 2 0.5, 1.4 2 0.2, and 3.8 2 1.0 X lo7, respectively). Similarly, there was a decrease in the total number of B220+ spleen cells in CSF-I-/-GM-CSF-/-mice compared with their wild-type littermates (2.4 t 0.7 and 6.6 2 0.9 X lo7, respectively).. Compared with their wild-type littermates, young CSF-.l -'-GM-CSF-" mice were also characterized by a significant increase in the pioportion (Table 3 ) and total number of 7/4+ cells (19.8 2 2.1 and 7.9 2 2.0 X IO6, respectively), an antigen expressed on neutrophils and activated macrophages.
With the age-related correction of bone marrow hematopoietic parameters, there was a similar resolution of the splenomegaly, spleen cellularity, and a return to normal values of the myeloid and lymphoid cell proportions in CSF-1-/-GM-CSF-I-mice (Table 3) as that previously described in the op/op mouse.I6 In addition, the incidence (Table 4) and content of splenic LPP-CFC and HPP-CFC decreased to become comparable to that of wild-type littermates. By 40 weeks of age, there were no differences in the measured hematopoietic characteristics between the spleens of CSFl-/-GM-CSF-/-, op/op, and wild-type mice, except for the continued increase in both the proportion (Table 3 ) and total number of 7/4+ cells in CSF-l-I-GM-CSF-" and op/op mice compared with their wild-type littermates (7.8 2 2.1, 10.2 2 1.4, and 4.6 2 1.7 X lo6). (Table 5 ). No differences were seen in the Propomon of F4/80+ cells, in either CSF-1-/-GM-CSF-" or op/op mice compared with wild-type mice at either 5 or after 40 weeks of age (Table 5 ). This observation is in agreement with peripheral blood differential counts, in which no diffbrences were seen in the number of monocytes (data not shown).
Age-related changes in peripheral blood immunophenotypes. A panel of MoAbs was also used to analyze the peripheral blood cell types
At 5 weeks of age, both young CSF-I-/-GM-CSF"-and op/op mice had a significant increase in the proportion of Gr-l+ cells as well as a decrease in the proportion of B220' lymphocytes compared with that of their wild-type littermates (Table 5 ). However, although this difference was reflected in the total numbers of these cell types (1 1. l 2 2.2, 12.8 2 1.4, and 5.8 2 0.9; and 5.9 t 0.7, 7.0 2 0.04, and 9.4 2 1.7 X 105/mL, respectively), the changes were not significant. By 40 weeks of age, the proportion of expression (Table 5 ) and total number of all surface antigens examined were comparable in CSF-l -/-GM-CSF-/-, op/op, and wildtype mice.
Age-related changes in peritoneal cell immunophenotypes. Significantly fewer cells were recovered from the peritoneum of both CSF-l-l-GM-CSF-" and op/op mice compared with that of their wild-type littermates at both 5 and 40 weeks of age (Table 6 ). Consequently, there were significantly less cells of all types analyzed within the peritoneal lavages of both CSF-l-"GM-CSF-/-and op/op mice compared with their wild-type littermates at both ages. Analysis of peritoneal macrophages showed an additional significant decrease in the proportion of F4/80+ cells in both CSF-l-"GM-CSF-'-and op/op mice compared with their wild-type littermates at both 5 and 40 weeks of age. No age- related increase in this population was detected in either CSF-l-I-GM-CSF-" or op/op mice ( Table 6 ).
The proportion of B220+ peritoneal cells was significantly increased in both 5-week-old CSF-l-'-GM-CSF-" and op/ op mice compared with wild-type littermates ( Table 6) . Although, because of the significant reduction in peritoneal cellularity, the total number of B220+ cells remained significantly lower in both 5-week-old CSF-l-/-GM-CSF-/-and op/op mice compared with wild-type littermates (2.7 ? 0.4, 1.1 2 0.1, and 5.3 -t 1.6 X lo5, respectively). Similarly, although no differences in the proportion of B220+ peritoneal cells could be detected by 40 weeks of age, the total number of peritoneal B220+ cells in CSF-l-/-GM-CSF-/-and op/op mice compared with wild-type littermates remained significantly reduced (1.2 ? 0.9, 2.1 ? 0.5, and 50.0 -t 16.3 X lo5, respectively), because no age-related correction in peritoneal cellularity was observed.
The proportion of CD4+ andor CD8+ cells was significantly increased in 5-week-old CSF-l"-GM-CSF-/-mice compared with wild-type littermates (Table 6) . However, as a consequence of the significant reduction in peritoneal cellularity in 5-week-old CSF-l-/-GM-CSF-'-mice compared with wild-type littermates (Table 6) , there was no significant difference in the total number of CD4+ andor CD8+ cells (1.4 ? 0.1 and 1.4 ? 0.3 X lo5, respectively). By 40 weeks of age, the proportion of CD4+ andor CD8+ cells in both op/op and CSF-l-/-GM-CSF-/-mice remained significantly higher than wild-type littermates, but, because there was no increase in peritoneal cellularity, no significant difference was detected between the total numbers of CD4' and/or CD8+ cells in CSF-l-"GM-CSF-'-and op/op mice compared with wild-type littermates (1.5 ? 0.7, 3.2 ? 1.1, and 17.2 2 7.5 X lo5, respectively).
DISCUSSION
This study demonstrates that young CSF-l-/-GM-CSF-" mice have the same hematopoietic characteristics and deficiencies as we previously described for the op/op mouse.14-lh Young CSF-l -/-GM-CSF-/-mice had a severe deficiency in bone marrow cellularity and macrophage content. During this period of suppressed marrow hematopoiesis, the spleen played a primary hematopoietic role.
The CSF-l-"GM-CSF-/-mouse also undergoes a similar age-related correction of the hematopoietic deficiencies evident in the young mouse as that described in the op/op mouse.14-16 All measured hematopoietic parameters, except for peritoneal cellularity and macrophage content, became comparable to that of wild-type littermates by 40 weeks of age. Therefore, as with the op/op mouse, the osteopetrosis and hematopoietic deficiencies in young CSF-l-/-GM-CSF-/-mice are not permanent, but undergo a progressive age-related correction. Values are the means t SEM of analysis in at least three individual mice.
Abbreviation: ND, not done. P < .05.
t Anti-CD4 and anti-CD8 were used as an antibody cocktail.
ROLE OF GM-CSF IN THE OHOP MOUSE 71
It is interesting to note that there was a comparable incidence and content of peripheral blood monocytes in CSFl"-GM-CSF-", op/op, and wild-type mice at all ages examined. In addition, there was no age-related correction of the deficiencies in peritoneal cellularity or macrophage content in either CSF-l-"GM-CSF-/-or op/op mice by 40 weeks of age, suggesting an essential requirement for CSF-1 for this macrophage subpopulation. These findings are in agreement with the data recently published by Cecchini et al, 38 whose observations also indicate differences in the dependency of various subpopulations of mononuclear phagocytes on CSF-l-/-GM-CSF-/-mice have a pulmonary pathology often complicated by infectionz3 that may have an impact on the hematopoietic profile we have described. For example, the increase in splenic 7/4+ cells can be explained by an increase in activated macrophages, perhaps resulting in part from the pulmonary pathology. This finding is consistent with the large increase in F4/80+ splenic cells, both proportionally and numerically.
Other studies have indicated that the daily administration of CSF-1 to newborn op/op mice is required to prevent osteopetrosis and the accompanying hematopoietic deficien~i e s . " , '~ Our previous studies have shown that the hematopoietic system has the capacity to use alternative mechanisms to compensate for the absence of biologically active CSF-1 in op/op mi~e.'~''~ The present study demonstrates conclusively that one of the growth factors that might have been suspected to ameliorate the hematopoietic deficiencies involved, GM-CSF, is not essential for the correction of the hematopoietic deficiencies in the op/op mouse, particularly in macrophage development.
The data also show that neither GM-CSF nor CSF-1 is an absolute requirement for the commitment of primitive hematopoietic stem cells to the macrophage lineage or for the differentiation of at least some classes of macrophages. This finding suggests that an alternate, regulatory growth factor can be involved in macrophage production and function in vivo. This may be an as yet unidentified factor or may be a manifestation of plasticity among the known hematopoietic factors." CSF-l.
